Liverpool University Hospitals NHS Foundation Trust

Specialist MDT: Liverpool University Hospitals NHS Foundation Trust

NB On 1 October 2019, Royal Liverpool and Broadgreen Hospitals and Aintree University Hospital merged to become Liverpool University Hospitals NHS Foundation Trust.

View Provider Services

The following services are available at this hospital trust (updated 2021). Men diagnosed at this trust may be able to access additional services from other trusts within the specialist multidisciplinary team:

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Transrectal ultrasound (TRUS) biopsy
    • Choline PET
    • PSMA (prostate-specific membrane antigen) PET scan
    • Whole body MRI
    • Isotope bone scan
  • Treatment Facilities:
    • Radical prostatectomy
    • Robot assisted laparoscopic prostatectomy
    • External beam radiotherapy (EBRT)
    • Stereotactic body radiation therapy (SBRT)
    • Chemotherapy
    • Joint specialist MDT clinic
    • Clinical trials unit
  • Support Service Facilities:
    • Clinical Nurse Specialist (CNS) in all clinics
    • Advanced PCa CNS
    • Urology CNS
    • Sexual function services
    • Psychological counselling
    • Genetic counselling

Data Quality

For these results, data for England were provided for 1st April 2019 to 31st March 2020 from the Rapid Cancer Registration Dataset (RCRD), which is sourced mainly from the Cancer Services and Outcomes Dataset (COSD) containing proxy tumour registrations, as the standard Cancer Registration data were unavailable. More details can be found here. Please note: the data quality results were amended in May 2022.

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 356 630
Performance Status recorded 85% 87%
TNM completed 70% 63%
Stage variable assigned 82% 81%

Disease Presentation

Specialist MDT National
No. of men with disease status determined 512 34801
Percentage of men diagnosed with metastatic disease 12% 13%

Management

These indicators could not be reported this year for England as we were unable to assign a patient to a particular risk group due to the unavailability of information on PSA and Gleason score in the Rapid Cancer Registration Dataset

Outcome

Treatment Centre
No. of men who received radical prostatectomy (2019-2020) 141
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 11%
No. of men who received radical prostatectomy (2018) 110
Adjusted percentage of men experiencing at least one GU complication (%) 2%

Compare provider outcomes